Skip to main content
Article
A86 CANNABIS USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS HIGHER FOLLOWING LEGALIZATION OF CANNABIS IN CANADA AND IS ASSOCIATED WITH LOWER QUALITY OF LIFE
Journal of the Canadian Association of Gastroenterology (2020)
  • Samuel Asfaha, Western University
Publication Date
2020
Citation Information
Samuel Asfaha. "A86 CANNABIS USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS HIGHER FOLLOWING LEGALIZATION OF CANNABIS IN CANADA AND IS ASSOCIATED WITH LOWER QUALITY OF LIFE" Journal of the Canadian Association of Gastroenterology (2020)
Available at: http://works.bepress.com/samuel-asfaha/31/